ArticleLaryngoscope investigative otolaryngology2026
Cross-Cultural Adaptation, Validity, and Reliability of the Dysphonia Risk Screening Protocol-General for Turkish-Speaking Individuals.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Screening is a critical first step in the early identification and prevention of voice disorders, particularly among at-risk populations. The Dysphonia Risk Screening Protocol-General (DRSP-G) is a comprehensive screening tool that also functions as a standardized patient history; however, no equivalent instrument has previously been available for Turkish-speaking individuals. This study aimed to translate and culturally adapt the DRSP-G into Turkish (DRTP-TR) and to examine its validity and reliability. Methods and Procedures: The DRSP-G was translated following the Scientific Advisory Committee of the Medical Outcomes Trust (SAC) guidelines, which comprise forward and backward translation, expert review, and a pilot study. A total of 140 participants (70 dysphonic, 70 healthy) across three groups: women, men, and children completed the DRSP-G. Validity was assessed using known-groups comparisons and correlations with the Voice Handicap Index, Pediatric Voice Handicap Index, auditory-perceptual (GRBAS) ratings, and acoustic measures. Receiver operating characteristic (ROC) analysis was used to determine cutoff scores. Reliability was evaluated via test-retest and inter-rater analyses. Outcomes and Results: DRTP-TR scores significantly differentiated dysphonic from healthy participants across all groups ( Conclusion and Implication: The DRTP-TR is a valid and reliable screening instrument for dysphonia risk among Turkish-speaking individuals across age and gender groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.